Longevity - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information. 

Autoimmune thyroiditis Part 2 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 2 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness

Autoimmune thyroiditis Part 1 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

Erin - US: Hashimoto's, Lupus, Depression (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I’d to introduce Erin from the United States who takes LDN for hypopituitary or as it's sometimes called secondary adrenal insufficiency. Hashimoto's thyroiditis, lupus and depression. Thanks for joining me, Erin.